ID: ALA2322005

Max Phase: Preclinical

Molecular Formula: C22H22Cl2O3

Molecular Weight: 405.32

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C=C(c1ccc(Cl)cc1)[C@H]1OOC2(CCCCC2)O[C@@H]1c1ccc(Cl)cc1

Standard InChI:  InChI=1S/C22H22Cl2O3/c1-15(16-5-9-18(23)10-6-16)20-21(17-7-11-19(24)12-8-17)25-22(27-26-20)13-3-2-4-14-22/h5-12,20-21H,1-4,13-14H2/t20-,21-/m1/s1

Standard InChI Key:  LBAHYNBUTSCUKE-NHCUHLMSSA-N

Associated Targets(non-human)

Plasmodium yoelii nigeriensis 1119 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Liver microsomes 8692 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Plasma 10718 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Intestine 155 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 405.32Molecular Weight (Monoisotopic): 404.0946AlogP: 6.76#Rotatable Bonds: 3
Polar Surface Area: 27.69Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 7.23CX LogD: 7.23
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.53Np Likeness Score: 0.44

References

1. Maurya R, Soni A, Anand D, Ravi M, Raju KS, Taneja I, Naikade NK, Puri SK, Wahajuddin, Kanojiya S, Yadav PP..  (2013)  Synthesis and antimalarial activity of 3,3-spiroanellated 5,6-disubstituted 1,2,4-trioxanes.,  (2): [PMID:24900640] [10.1021/ml300188t]

Source